Home » Topics » BioWorld Science

BioWorld Science
RSS

Acurx presents first-in-human data for ACX-362E

Feb. 28, 2019

NIAID is recruiting participants in phase I study of VRC-FLUNPF099-00-VP influenza vaccine

Feb. 28, 2019

Miransertib shows promising therapeutic efficacy in children with Proteus syndrome

Feb. 28, 2019

Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery present AR antagonists

Feb. 28, 2019

First patient dosed ORIENT-32 study of Tyvyt plus IBI-305 in HCC

Feb. 28, 2019

Nodthera patents NLRP3 inflammasome inhibitors

Feb. 28, 2019

New PI3Kgmma and PI3Kdelta inhibitors discovered at Columbia University

Feb. 28, 2019

B7-H3.CAR-Ts demonstrate promising efficacy and safety in preclinical cancer models

Feb. 28, 2019

Sunshine Lake Pharma identifies new semicarbazide-sensitive amine oxidase inhibitors

Feb. 28, 2019

Eisai to support AAR Japan program to raise awareness of mycetoma in Sudan

Feb. 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...